Fig. 7
From: Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19
Subgroup analysis of various factors associated with all-cause death in patients.
Fig. 7 | Scientific Reports
From: Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19
Subgroup analysis of various factors associated with all-cause death in patients.
